Israeli biotech Advanced Inhalation Therapies (AIT), plans to raise $12 million on NASDAQ. AIT (new name Beyond Air) develops products for the treatment of respiratory infections including Cystic Fibrosis. See previous newsletter articles (here) of its Nitric Oxide treatment.
http://www.globes.co.il/en/article-advanced-inhalation-therapies-set-for-12m-nasdaq-ipo-1001098247